ArticleDrugs in R&D2015

Effect of a modified saquinavir/ritonavir dosing regimen with lower dose lead-in phase on QTc interval, pharmacokinetics, antiviral activity and safety in treatment-naïve HIV-1-infected patients.

Marta Boffito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.